NST-628 is a selective, non-peptidic small molecule inhibitor of the protein kinase CK2, primarily utilized in oncology research to investigate pathways involved in cancer cell proliferation and survival.… Read more
NST-628 is a selective, non-peptidic small molecule inhibitor of the protein kinase CK2, primarily utilized in oncology research to investigate pathways involved in cancer cell proliferation and survival. This compound acts as a critical reference standard for scientists exploring the therapeutic potential of targeting CK2 in solid tumors. Pharmaceutical laboratories rely on related compounds in this category, including synthesis impurities, metabolic breakdown products, and stable isotope-labelled versions of the drug, to conduct rigorous analytical testing. These high-purity reference materials are essential for impurity profiling, method validation, and accurate quantification in biological matrices using techniques like high-resolution mass spectrometry. By employing these specialized standards, researchers and quality control professionals ensure the integrity and reliability of their data throughout the development and evaluation of formulations involving this specific kinase inhibitor.